
{
    "Variants Include": [
        {
            "Gene": "LRRK2",
            "variants": [
                {
                    "HGVS": "NM_198578.4:c.7153G>A",
                    "cDNA Change": {
                        "transcript": "NM_198578.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "7153"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "R",
                        "position": "2385"
                    },
                    "Description in input context": "rs34778348:G4A; p.G2385R"
                },
                {
                    "HGVS": "NM_198578.4:c.4883G>C",
                    "cDNA Change": {
                        "transcript": "NM_198578.4",
                        "ref": "G",
                        "alt": "C",
                        "position": "4883"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "P",
                        "position": "1628"
                    },
                    "Description in input context": "rs33949390:G4C; p.R1628P"
                },
                {
                    "HGVS": "NM_198578.4:c.4193G>A",
                    "cDNA Change": {
                        "transcript": "NM_198578.4",
                        "ref": "G",
                        "alt": "C",
                        "position": "4193"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "H",
                        "position": "1398"
                    },
                    "Description in input context": "rs7133914:G4C; p.R1398H"
                },
                {
                    "HGVS": "NM_198578.4:c.1653C>G",
                    "cDNA Change": {
                        "transcript": "NM_198578.4",
                        "ref": "C",
                        "alt": "A",
                        "position": "1653"
                    },
                    "Protein Change": {
                        "ref": "N",
                        "alt": "K",
                        "position": "551"
                    },
                    "Description in input context": "rs7308720:C4A; p.N551K"
                },
                {
                    "HGVS": "NM_198578.4:c.4939T>A",
                    "cDNA Change": {
                        "transcript": "NM_198578.4",
                        "ref": "T",
                        "alt": "A",
                        "position": "4939"
                    },
                    "Protein Change": {
                        "ref": "S",
                        "alt": "T",
                        "position": "1647"
                    },
                    "Description in input context": "rs11564148:T4A; p.S1647T"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson Disease",
        "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
        {
            "Assay Method": "In vitro kinase assay",
            "Material used": {
                "Material Source": "Protein",
                "Material Name": "LRRK2 variants",
                "Description": "In vitro kinase assay was performed using 2 mg ASK1 or 1–8 mg of LRRK2 variants incubated in 50 μl of kinase buffer containing 20 mM HEPES, 10 mM MgCl₂, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 5 mM NaF, 5 mM Na₃VO₄ with 5 mg of MBP. LRRK2 variants were affinity-purified using GFP antibody. Eluate proteins were concentrated by size exclusion in centrifugal filter devices."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_198578.4:c.7153G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "p.G2385R showed higher autokinase activity and increased MBP phosphorylation than wild type."
                },
                {
                    "Variant": "NM_198578.4:c.4883G>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "p.R1628P showed higher autokinase activity and increased MBP phosphorylation than wild type."
                },
                {
                    "Variant": "NM_198578.4:c.4193G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "p.R1398H had significantly lower autokinase activity and reduced MBP phosphorylation than wild type."
                },
                {
                    "Variant": "NM_198578.4:c.1653C>G",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "N.D."
                },
                {
                    "Variant": "NM_198578.4:c.4939T>A",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "p.S1647T’s autokinase activity and MBP phosphorylation were similar to wild type."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Established kinases (ASK1) showed specific phosphorylation of their specific substrate (MBP), validating conditions used in the experiments."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "‘No kinase’ control was used, showing no phosphorylation of MBP."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Student’s t-test (for comparisons between variants and wild type)"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Kinase activity within wild type range",
                "Source": "Wild type LRRK2 activity"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Significantly higher or lower kinase activity than wild type (p < 0.05)",
                "Source": "Statistical significance relative to wild type"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}